To end the tuberculosis (TB) epidemic, the World Health Organization (WHO) recommends
improving access to testing and treatment of latent TB infection (LTBI)[1]. Despite recent …

Adverse effects (AE) to TB treatment cause morbidity, mortality and treatment interruption.
The aim of these clinical standards is to encourage best practise for the diagnosis and …

This chapter discusses the global and local epidemiology, clinical features, and recent
selected advances and challenges in the prevention and treatment of TB/HIV disease. Drug …

Background: Tuberculosis (TB) is the leading cause of health complications and death
among human with immunodeficiency virus (HIV) infection. When TB develops during …

An estimated one-quarter of the world population has latent TB infection (LTBI) and 5–10%
of those will develop TB disease during their lifetime. Treatment of LTBI can decrease the …

Diagnostic tests play a crucial role in the control and surveillance of infectious diseases, and
to ensure effective clinical management. Novel diagnostic tests are traditionally evaluated in …

When a new treatment regimen is expected to have comparable or slightly worse efficacy to
that of the control regimen but has benefits in other domains such as safety and tolerability, a …

Executive summary The World Health Organization (WHO) Global Tuberculosis Programme,
in collaboration with University College London and other partners, convened a virtual …

The study aimed at identifying the determinants of tuberculosis infection among human
immunodeficiency virus (HIV) positive adolescents and subsequently develop a prevention …

Аннотация Цель. Оценить современный взгляд на проблему туберкулеза (ТБ) у
беременных и родильниц. Материалы и методы. Выполнен поиск в электронных базах …